CVE-2019-6538

CVE-2019-6538 is a critical-severity vulnerability in Medtronic Mycarelink Monitor Firmware with a CVSS 3.x base score of 9.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-306.

Key facts

Description

The Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement authentication or authorization. An attacker with adjacent short-range access to an affected product, in situations where the product’s radio is turned on, can inject, replay, modify, and/or intercept data within the telemetry communication. This communication protocol provides the ability to read and write memory values to affected implanted cardiac devices; therefore, an attacker could exploit this communication protocol to change memory in the implanted cardiac device.

Frequently asked questions

What is CVE-2019-6538?
The Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement authentication or authorization. An attacker with adjacent short-range access to an affected product, in situations where the product’s radio is turned on, can inject, replay, modify, and/or intercept data within the telemetry communication. This communication protocol provides the ability to read and write memory values to affected implanted cardiac devices; therefore, an attacker could exploit this communication protocol to change memory in the implanted cardiac device.
How severe is CVE-2019-6538?
CVE-2019-6538 has a CVSS 3.x base score of 9.3, rated critical severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability high.
Is CVE-2019-6538 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (54th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2019-6538?
CVE-2019-6538 primarily affects Medtronic Mycarelink Monitor Firmware. In total, 21 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2019-6538?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2019-6538 published?
CVE-2019-6538 was published on 2019-03-25 and last updated on 2026-06-17.

References

Affected products (21)

Other CWE-306 (Missing Authentication for Critical Function) vulnerabilities

Browse all CWE-306 (Missing Authentication for Critical Function) vulnerabilities →